HAYA Therapeutics
Programmable Therapeutics for Causal Biology - Science Guides Us. The Genome Powers Us. Patients Ground Us.
68 employees · est. 2019 · Switzerland
Systems Oncology
Deeper Insights, Multimodal Drugs - We translate genomic intelligence into multi-targeting therapies.
9 employees · est. 2015 · Scottsdale, United States
Systems Oncology is the older company (2019 vs 2015); HAYA Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | HAYA Therapeutics | Systems Oncology |
|---|---|---|
| Founded | ||
| Founded | 2019 | 2015 older |
| Headquarters | ||
| Headquarters | Switzerland | Scottsdale, United States |
| Employees | ||
| Employees | 68 larger | 9 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Biotechnology, Health Care, Information Technology |
| Funding Stage | ||
| Funding Stage | Undisclosed | Not tracked yet |
| Total Funding | ||
| Total Funding | $1.02B | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | 9 | Not tracked yet |
| Services | ||
| Services | Development of precise RNA therapies for reprogramming disease driving cell-states | In silico discovery research, Prioritization using in silico insights, In-licensing of experimental agents, Investment in efficacy and mechanism studies, Out-licensing products to pharmaceutical companies |
| Target Customers | ||
| Target Customers | Patients suffering from rare and chronic diseases | Pharmaceutical Companies, Research Institutions, Oncologists, Biotech Investors |
| Taxonomy | ||
| Taxonomy | RNA-based Therapeutics, Precision Medicine, Cardiovascular Disease Treatment, Cancer Treatment, Long Non-coding RNAs (lncRNAs), Cell-specific Therapeutics, Biopharmaceutical Therapy, Genomic Medicines, Fibrosis Treatment, Disease-modifying Therapeutics | Genomic Intelligence, Multimodal RNA Therapeutics, Oncology, Drug Resistance, RNA Molecule, Arromer Platform, Self-Delivering Therapeutics, Polygenic Disease, Cognitive Computing Technologies, Biomedical Data Analysis, Cancer Vulnerabilities, Cutting-Edge Agents, Cancer Therapies, Research And Development |
| Website | ||
| Website | hayatx.com | systemsoncology.com |
About HAYA Therapeutics
HAYA Therapeutics is a precision medicines company focused on developing RNA-guided programmable therapeutics targeting the regulatory genome to address serious health conditions such as cardiovascular disease and cancer. The company's innovative cell-state modifying platform provides novel insights...
About Systems Oncology
Systems Oncology, founded in 2015, is redefining treatment paradigms in the biotechnology and healthcare sectors with its innovative multimodal RNA therapeutics. Headquartered in the United States, the company is focused on disrupting traditional approaches to combat complex diseases with its cuttin...
We will tell you when either one moves
BounceWatch watches HAYA Therapeutics and Systems Oncology for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at HAYA Therapeutics and Systems Oncology — by email.
Frequently Asked Questions
Compare HAYA Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at HAYA Therapeutics on 9 Jun 2026, and Systems Oncology on 30 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.